Last Posted: May 08, 2020
- A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
Cui Yingnan et al. Cancer genetics 2019 23954-61 - Updates in BRCA testing for People of Ashkenazi Jewish Ancestry
L Steinmark, Jackson Labs, May 3, 2020 - Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Talhouet Solene De et al. Scientific reports 2020 Apr 10(1) 7073 - Genetic testing costs and compliance with clinical best practices.
Montanez Kathleen et al. Journal of genetic counseling 2020 May - Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History
AP Patel, JAMA Network Open, April 29, 2020 - Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction.
Stjepanovic Neda et al. European journal of cancer (Oxford, England : 1990) 2020 Apr 13253-60 - BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific.
Cifuentes-C Laura et al. Colombia medica (Cali, Colombia) 2019 Sep 50(3) 163-175 - Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an 'oncogenetic taskscape'.
Wright Sarah et al. Social science & medicine (1982) 2019 22526-33 - Mainstream consent programs for genetic counseling in cancer patients: A systematic review.
Scheinberg Tahlia et al. Asia-Pacific journal of clinical oncology 2020 Apr - Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing.
Vlessis Katherine et al. JNCI cancer spectrum 2020 Feb 4(1) pkz095
.png)
No hay comentarios:
Publicar un comentario